The company indicates it plans to continue to manage and operate under the bankruptcy filing while it works with Cowen and Company to develop a plan forward. Source: BioSpace

The trial met its primary endpoint of progression-free survival but did not improve overall survival, a secondary endpoint. Source: BioSpace

Teva may be passing out more pink slips as the company looks to cut up to 10,000 jobs in order to save up to $2B in costs over the next…

These data led to FDA Breakthrough Therapy and EMA PRIME (PRIority MEdicines) designations. Source: BioSpace

Layoffs are expected to begin in February, according to reports. Source: BioSpace

The expansion will nearly double its employment. Source: BioSpace

One of the most important points about Hemlibra’s approval, beyond its significant efficacy is the positive impact it will have one the quality of life for these hemophilia patients. Source:…

Medivir will continue to receive royalties on any remaining sales of Olysio/Sovriad (simeprevir) that Janssen will make until that time. Source: BioSpace

Biotech companies have a number of pivotal challenges in going from a promising compound to commercially viable products. Source: BioSpace

The study enrolled a total of 123 patients at 30 European sites. Source: BioSpace